ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1827

Transcriptomics and Machine Learning Unraveling the Molecular Drivers of PFAPA Flares

Sivia Lapidus1, Tresa Ambooken2, Ellen Hakim3, Tara Lozy4, Elahe Golalipour3, Sohail Adonimohammed5, Jennifer Weiss6, Suzanne Li6, Amanda Nowakowski7, Aryeh Lejtman8, Aaron Sebbag3, Ariel Aptekmann9 and Jigar Desai9, 1Joseph M. Sanzari Children's Hospital, Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Montclair, NJ, 2Food and Drug Administration, Floral Park, NY, 3Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 4Joseph M. Sanzari Children's Hospital, Center for Discovery and Innovation, Hackensack Meridian School of Medicine, Nutley, 5Hackensack Meridian School of Medicine, Nutley, NJ, 6Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ, 7Joseph M. Sanzari Children's Hospital, Hackensack Meridian Health, Hackensack, NJ, 8Joseph M. Sanzari Children's Hospital and Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ, 9Center for Discovery and Innovation and Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, NJ

Meeting: ACR Convergence 2025

Keywords: Autoinflammatory diseases, Biomarkers, informatics, innate immunity, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1809–1829) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) is the most common periodic fever presenting with frequent episodes of pain and impaired function. While its etiology remains unknown, evidence suggests a genetic component and dysregulation of innate immunity. Our objective is to develop transcriptomic insights into the molecular pathways predicting PFAPA flares.

Methods: Ten PFAPA patients, fulfilling consensus patient characteristics, had blood samples collected during flare and non-flare times. Differences between groups were analyzed with the paired t-test. Differentially Expressed Genes (DEGs) were analyzed with standard RNA sequencing pipelines, including quality control, alignment to the reference genome (hg39), and quantification of transcript levels (STAR). Genes with significant differential expression were identified (DESeq2) and analyzed for pathway enrichment (gseapy). We trained a random forest (RF) classifier on gene expression counts to distinguish between flare and non-flare states, obtaining a final model with area under the ROC curve of 1. Top-ranked features’ biological relevance to understand key pathways driving disease flares were evaluated.

Results: The PFAPA cohort’s age of onset was 32 (IQR; 12-78) months, maximum temperature of 104.9 (IQR 103.4-105.2) degrees Fahrenheit, fever duration of ~4 (IQR:3-4.25) days and an 8 out of 10 in severity (IQR: 6-8,9) with how an episode feels and affects function. During flares, 100% of patients had pharyngitis, 80% cervical lymphadenopathy, and 50% oral aphthae. Lab abnormalities with flare included leukocytosis, neutrophilia, monocytosis, lymphopenia, and increased CRP (P < 0.01). A clear distinction between flare and non-flare gene expression was identified by RNA-sequencing Principal Component Analysis with multiple DEGs (Fig. 1). The top 50 DEGs by adjusted p-value included upstream regulators of immune pathways (CD177, GPR84, C1QC, and CARD17P). Gene Set Enrichment Analysis identified neutrophilic, interferon, response to organism and protein processing as key inflammatory pathways. Differentially regulated pathway signatures are depicted in Fig. 2. The top 20 features from the RF of flare versus non-flare were related to cell cycle arrest and microtubule polymerization. The highest-ranking feature was microRNA 5195 (downstream effectors Fig. 3), which at low levels was most predictive of flare.

Conclusion: We identified distinct gene expression profiles between PFAPA states demonstrating a transcriptomic signature of immune dysregulation associated with flares. The flare state reflects neutrophilic activation (modulated by corticosteroids aborting fever), interferon signaling, innate immune dysregulation and heightened cellular activity manifesting as cell cycle arrest as well as microtubule polymerization (modulated by colchicine). The MicroRNA 5195 gene was identified as the highest-ranking predictive feature of PFAPA flares. Future work incorporating machine learning models in prioritizing biologically relevant markers in comparison to other cohorts will enable future development of a unique potential PFAPA biomarker.

Supporting image 1Figure 1: (Left) Principal Component Analysis Showing a Clear Separation and (Right) MA Plot of Log Fold Change Between PFAPA Flare and Non-Flare Plotted Against Mean Gene Expression. Significantly altered genes at p value < 0.05 are marked in color .

Supporting image 2Figure 2: Gene Expression Signatures between PFAPA Flare and Non-Flare for Gene Ontologies Associated with Inflammation

Supporting image 3Figure 3: Network Motif of MICRO-RNA 5195: Downstream Effectors


Disclosures: S. Lapidus: None; T. Ambooken: None; E. Hakim: None; T. Lozy: Eli Lilly & Company, 11; E. Golalipour: None; S. Adonimohammed: None; J. Weiss: None; S. Li: Boehringer-Ingelheim, 2, Merck/MSD, 12, Spouse was an employee and receiving pension from them; A. Nowakowski: None; A. Lejtman: None; A. Sebbag: None; A. Aptekmann: None; J. Desai: None.

To cite this abstract in AMA style:

Lapidus S, Ambooken T, Hakim E, Lozy T, Golalipour E, Adonimohammed S, Weiss J, Li S, Nowakowski A, Lejtman A, Sebbag A, Aptekmann A, Desai J. Transcriptomics and Machine Learning Unraveling the Molecular Drivers of PFAPA Flares [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/transcriptomics-and-machine-learning-unraveling-the-molecular-drivers-of-pfapa-flares/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/transcriptomics-and-machine-learning-unraveling-the-molecular-drivers-of-pfapa-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology